Prelude Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $1.74M | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $1.1M | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $387K | Sell |
|
|||||
|
2022
Q1 | $432K | Sell |
|
|||||
|
2021
Q4 | $866K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $2.67M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $201K | Sell |
|
|||||
|
2020
Q3 | $1.06M | Buy |
|
|||||
|
2020
Q2 | – | Hold |
|
|||||
|
2020
Q1 | – | Hold |
|
|||||
|
2019
Q4 | – | Hold |
|
|||||
|
2019
Q3 | – | Hold |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $2.16M | Buy |
|
|||||
|
2018
Q4 | $1.01M | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $33K | Sell |
|
|||||
|
2017
Q4 | $666K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $538K | Buy |
|
|||||
|
2017
Q1 | $40K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $130K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $521K | Sell |
|
|||||
|
2015
Q4 | $693K | Buy |
|
|||||
|
2015
Q3 | $587K | Buy |
|
|||||
|
2015
Q2 | $453K | Sell |
|
|||||
|
2015
Q1 | $1.37M | Buy |
|
|||||
|
2014
Q2 | – | Hold |
|
|||||
|
2014
Q1 | – | Hold |
|